Daily News & Analysis |
PPIs Boost Gastric Ca Risk in H. Pylori Patients
MedPage Today The long-term use of proton pump inhibitors (PPIs) could more than double gastric cancer risk in patients successfully treated for Helicobacter pylori infection, according to researchers. Analysis of the Hong Kong Hospital Authority database showed ... Heartburn and Acid Reflux Drugs Double Risk of Stomach Cancer Common acid reflux drugs may more than double risk of stomach cancer Are Some Heartburn Meds Tied to Stomach Cancer? |
from Health - Google News http://ift.tt/2iTZ6Iq
EmoticonEmoticon